IHIF Welcomes ImmuneWorks LLC as New Member

IHIF is pleased to welcome ImmuneWorks LLC as a returning member. A biotechnology company committed to developing novel therapies for autoimmune diseases, ImmuneWorks was founded in 2006 to develop safe and effective immune tolerance treatments for patients with serious autoimmune diseases of the lung. The scientific foundation of the company is ImmuneWorks’ groundbreaking discovery that antigen-specific autoimmunity is responsible for the disease in over one-half of idiopathic pulmonary fibrosis (IPF) patients. ImmuneWorks’ initial focus is to develop and commercialize immune tolerance therapies and coupled diagnostic products to help people with IPF while building an immune tolerance platform in multiple autoimmune diseases.

For more information on ImmuneWorks, please visit www.immuneworks.com


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: